Even if it seems like a good idea that should work, if the evidence isnt there, then such a treatment should only proceed in a setting that can generate the essential evidence. Jeff Levin-Scherz, M.D., the population health leader for health and benefits in North America at Willis Towers Watson, noted that GLP-1 drugs have been in use since 2005
Mann JF, Fonseca V, Mosenzon O, et al
To manage side effects, try to take your dose around the same time each week
Clinical trials and real-world data consistently show: Average weight loss of 1520% on semaglutide or tirzepatide Improvements in blood pressure, cholesterol, and blood sugar Reduced risk of developing type 2 diabetes and cardiovascular disease These outcomes are meaningful both for employee health and long-term cost avoidance
Weight Loss Composition is One-Fourth Fat-Free Mass: A Critical Review and Critique of This Widely Cited Rule: Weight Loss Composition. Obesity Reviews: An Official Journal of the International Association for the Study of Obesity
How Do GLP-1 Receptor Agonists Work